As of May 27, 2024 13bestnftgamestoearn:31. The Hong Kong Stock Pharmaceutical ETF(159718) rose 0.93%, with the latest price quoted at 0.54 yuan. The intraday turnover has reached 24.5595 million yuan, with a turnover rate of 14.21%. Market trading is active. Tracking index component Sansheng Pharmaceutical (01530) rose 5.39%, Shijiazhuang Pharmaceutical Group (01093) rose 3.60%, Jinxin Reproductive (01951) rose 3.41%, China Resources Pharmaceutical (03320) rose 3.37%, and Gushengtang (02273) rose 3.29%.
On the news front, the ASCO Conference, a world-renowned academic conference on oncology, will be held in Chicago, USA from May 31 to June 4, 2024. Many Chinese pharmaceutical companies have announced that their new drug research has been selected for this conference, which has attracted great attention from the market.
Relevant institutions pointed out that the current performance vacuum period is in place, short-term hot spots have subsided, and the pharmaceutical sector is relatively weak. However, the current pharmaceutical position is still at a low level and has dropped significantly month-on-month. Under the influence of high bases such as the release of the epidemic last year, recovery in hospitals, and overseas exports, 2024Q1 is expected to become the lowest point for the whole year, and Q2 is beginning to usher in a quarterly positive trend. As the domestic market policy environment continues to be optimized, admission work is gradually carried outbestnftgamestoearn; The impact of global inventories has been eliminated, regional political expectations have stabilized, the fundamentals of the pharmaceutical sector are expected to improve quarter by quarter, and a significant turning point is expected in the second half of the year. Based on the current position, fundamentals, etc., it is recommended to actively add medicines.
Southwest Securities pointed out that under the expectation of overseas macro interest rate cuts, the pharmaceutical industry still has structural opportunities based on the three dimensions of policy, valuation and fundamentals. 1) Innovation + going to sea is still the idea of continuing optimism;2) After medical anti-corruption, pay attention to the rigid medical needs in the hospital;3) Pay attention to "low valuation + performance reversal" individual stocks. In addition, there are still thematic investment opportunities for diet drugs and AI medical care this year.
The Hong Kong Stock Connect Pharmaceutical ETF closely tracks the China-Hong Kong Stock Connect Pharmaceutical and Health Composite Index. The China-Hong Kong Stock Connect Pharmaceutical and Health Composite Index selects 50 securities of listed companies in the medical and health industry with good liquidity and large market value from the scope of the China-Hong Kong Stock Connect as index samples to reflect the overall performance of securities of listed companies in medicine and health within the scope of the China-Hong Kong Stock Connect.
Hong Kong Stock Pharmaceutical ETF(159718), OTC connectivity (Class A: 019598; Class C: 019599).
The above content and data have nothing to do with the position of Lianyun Channel on the interface and do not constitute investment advice. Operate accordingly and bear the risks at your own risk.
